Medical devices company Mindray has introduced the new BeneHeart C Series automated external defibrillator (AED), designed for improved resuscitation in cases of sudden cardiac arrest (SCA).

Launched in multiple markets, including Europe, the device comes in fully and semi-automatic options. BeneHeart C features smarter operations and quick shock delivery.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The device is integrated with ResQNavi technology to direct users through the rescue process via step-by-step animation coaching and voice prompts.

It also leverages QShock technology to deliver the first shock within eight seconds. The BeneHeart C Series AED cuts ECG analysis time to five seconds and carries out concurrent pre-charging to save time.

Furthermore, the device offers 360J energy option when 200J fails to defibrillate.

Mindray designed the AED to be waterproof and dustproof, with drop endurance. It can be carried on all out-of-hospital transport, including helicopters and applied in different settings, added the company.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The device enables connection to the AED-Alert 2.0 system for safe fleet management. The cloud-based alert system automatically notifies the manager in case of any status change.

Mindray international patient monitoring & defibrillator business director Eason Zhou said: “Sudden cardiac arrest could happen to people of all ages and in any place.

“Having identified the challenges and needs of the AED market, Mindray developed BeneHeart C Series AED to help people perform effective SCA resuscitation more confidently. Our AED-Alert 2.0 lets AED owners manage their fleet of AEDs in a more efficient way.”

Founded in 1991, Mindray offers patient monitoring, life support, in-vitro diagnostics and medical imaging system products and services in more than 90 markets.

In addition to BeneHeart C Series, the company’s AED portfolio includes BeneHeart D1, alert systems and accessories.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact